You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00293644 ↗ Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy Completed Duchesnay Inc. Phase 3 2006-02-01 The purpose of this study is to determine whether pre-emptive use of a delayed release combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will reduce the incidence of severe forms of this syndrome/HG.
NCT00293644 ↗ Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy Completed The Hospital for Sick Children Phase 3 2006-02-01 The purpose of this study is to determine whether pre-emptive use of a delayed release combination of pyridoxine hydrochloride and doxylamine succinate (Diclectin®), before eruption of symptoms of Nausea and vomiting of pregnancy and hyperemesis gravidarum, will reduce the incidence of severe forms of this syndrome/HG.
NCT00614445 ↗ The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy Completed Premier Research Group plc Phase 3 2008-01-01 The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of pregnancy than a placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Condition Name

Condition Name for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Intervention Trials
Nausea and Vomiting of Pregnancy 2
Hyperemesis Gravidarum 1
Pregnancy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Intervention Trials
Vomiting 3
Nausea 2
Pregnancy Complications 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Trials by Country

Trials by Country for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Location Trials
China 6
United States 4
Mexico 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Location Trials
Texas 1
Pennsylvania 1
Maryland 1
District of Columbia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 3 3
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 3
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Sponsor Name

Sponsor Name for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Sponsor Trials
Duchesnay Inc. 2
Grünenthal, S.A. 1
Ningxia Hui Autonomous Region Hospital of TCM 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE
Sponsor Trials
Other 15
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.